Introduction
============

Mycoplasma species represent a large group of wall-less bacteria derived from a common ancestor to Gram-positive bacteria, such as *Clostridia* ([@B57]). Their evolution has been marked by loss of genetic material, resulting in some species, such as *Mycoplasma genitalium*, which are considered good natural representatives of minimal cells ([@B26]) because of their reduced genome. Genome down-sizing was not the sole force operating during mycoplasma evolution; it was recently shown that mycoplasmas sharing the same natural niche have exchanged significant amounts of their genome through horizontal gene transfer (HGT) ([@B49]; [@B43]). A few mobile genetic elements (MGE), including insertion sequences, phages, plasmids, and integrative and conjugative elements (ICEs), have been described in mycoplasmas ([@B7]; [@B35]) and may be involved in such genetic transfer.

Over the last several decades, there has been increasing appreciation of the role of ICEs in HGT ([@B8]; [@B16]). Their importance in bacterial evolution is underlined by their wide distribution across bacteria. These genetic elements are defined by two features: their integration in the host chromosome and their capacity to encode a type IV secretion system that mediates their transfer from the donor cell to the recipient cell via conjugation ([@B30]). Mycoplasma ICEs (MICEs) are emerging as pivotal factors in HGT of large DNA fragments in many mycoplasmas species ([@B14]; [@B22]). The first reported MICE was ICEF, a genetic element of 23 kb occurring in four copies in *Mycoplasma fermentans* PG18 ([@B12]), a human mycoplasma species of the Hominis phylogenetic group. A second MICE of 27 kb, designated as ICEA, was identified in three copies in *Mycoplasma agalactiae* strain 5632 ([@B36]), a ruminant mycoplasma belonging to the same phylogenetic group. Both MICEs are composed of about 20 structural genes, of which 12 are homologous. Similar MICEs have also been detected in other animal mycoplasma species, such as *Mycoplasma bovis* ([@B56]), *Mycoplasma mycoides* subsp. *capri*, and *Mycoplasma capricolum* subsp. *capricolum* ([@B52]). These self-transmissible elements belong to a new clade of the mutator-like superfamily and rely on a DDE recombinase for their mobility ([@B18]; [@B28]). In 2015, a comparative study including MICEs found, in several ruminant mycoplasmas species, a conserved, minimal MICE backbone composed of four coding sequences (CDSs) predicted to be essential for MICE self-dissemination across cells ([@B51]): CDS1, of unknown function, CDS22 encoding a DDE recombinase, and CDS5 and CDS17 encoding TraG/VirD4 and TraE/VirB4 homologs, respectively, which are predicted to be two essential components of the type IV secretion system required for DNA mobility ([@B14]). The detection of MICEs in several mycoplasma species of the Hominis phylogenetic group, which includes the human *M. fermentans* species, raised the question of whether they also occur in the human *M. hominis* species.

*Mycoplasma hominis* is present as a commensal in the lower urogenital tract but can be responsible for urogenital infections, neonatal infections, and extragenital infections in immunocompromised patients ([@B53]; [@B54]). Recent evidence of HGT with *Ureaplasma parvum*, a species sharing the same urogenital habitat, has been reported despite the absence of plasmids or transposons in the *M. hominis* type strain PG21 ([@B43]). The MGEs have rarely been described in other *M. hominis* isolates. To date, the transposon Tn*916* ([@B45]; [@B34]), other transposons carrying the *tet*(M) gene ([@B1]; [@B11]) and prophages ([@B1]; [@B10]) have been reported in *M. hominis* isolates. In addition, no MICE similar to those described in *M. fermentans* or ruminant mycoplasmas have been explored in *M. hominis*. In the present study, detection and characterization of *M. hominis* ICEs was performed in one reference strain and 11 clinical isolates by whole-genome sequencing and analyses. Common and specific *M. hominis* ICE (ICEHo) determinants were further defined by comparative genomics. In addition, the prevalence of ICEHos in *M. hominis* species was estimated by screening a collection of 120 clinical isolates.

Materials and Methods
=====================

Mycoplasma Strains
------------------

The genomes of reference strain M132 and 11 French clinical isolates of *M. hominis* were sequenced. The 11 clinical isolates were part of the isolate collection of the French National Reference Center for sexually transmitted bacterial infections and have been preserved at the Centre de Ressource Biologique-Bordeaux Biothèque Santé (CRB-BBS) of Bordeaux University Hospital under the collection number BB-0033-00094 and authorization AC-2014-2166 from the French Ministry of Higher Education and Research with no information regarding the patient identity from whom the isolate had been grown. These strains were chosen among a total of about 500 *M. hominis* isolates to ensure diversity in terms of sampling origin, multi-locus variable-number tandem-repeat (VNTR) analysis (MLVA) types and years of isolation ([Table 1](#T1){ref-type="table"}).

###### 

*M. hominis* strains used for genome sequencing.

  **Strain**   **Clinical context**       **Nature of the sample**   **Geographic origin**   **Year of isolation**   **MLVA type ([@B23])**
  ------------ -------------------------- -------------------------- ----------------------- ----------------------- ------------------------
  M132                                                               Reference strain                                10
  35           Neonatal fever             Blood culture              Bordeaux                1989                    8
  331          Psoriatic arthritis        Joint fluid                Bordeaux                1991                    15
  2674         Mediastinitis              Mediastinal suppuration    Paris                   1998                    10
  3299         Osteoarthritis             Joint fluid                Bordeaux                2002                    36
  3631         Endometritis               Amniotic liquid            Bordeaux                2004                    4
  4016         Endometritis               Endometrial biopsy         Lannion                 2005                    8
  4235         Salpingitis                Peritoneal fluid           Bordeaux                2006                    10
  4788         Vaginosis                  Vaginal secretions         Bordeaux                2008                    10
  5012         Commensal                  Semen                      Bordeaux                2009                    12
  5060         Vaginosis                  Vaginal secretions         Bordeaux                2009                    8
  5096         Maternal-fetal infection   Placenta                   Bordeaux                2009                    15

To determine the prevalence of ICE in *M. hominis* species, 120 clinical isolates randomly selected from among 183 isolates collected in a previous study (performed between 1 January 2010 and 31 December 2015 at Bordeaux University Hospital, France) were used ([@B38]). The sources of the samples were diverse and included 75 (62.5%) urogenital, 25 (20.8%) placental, 2 (1.7%) lower respiratory, 2 (1.7%) upper respiratory samples, 5 (4.2%) puncture liquids from different origin (1 cerebrospinal fluid, 1 puncture liquid from the pouch of Douglas, and 3 puncture liquids of unknown origin), as well as 11 (9.2%) samples of unknown origin. Among the 120 clinical isolates, 27 isolates harbored the *tet*(M) gene ([@B38]).

DNA Extraction
--------------

The extraction of genomic DNA was performed using Nucleobond^®^ AXG 20 columns with a Nucleobond Buffer set III kit (Macherey Nagel, Hoerdt, France) according to the manufacturer's instructions for Illumina sequencing, and using an increased initial culture volume of 10 mL for Oxford Nanopore sequencing to increase the DNA concentration. A NucleoSpin^®^ Tissue kit (Macherey Nagel) was used for DNA extraction for conventional PCR.

Sequencing and Assembly
-----------------------

Mate pair reads were generated with Illumina GAIIx technology for four strains, i.e., *M. hominis* 331, 3631, 4016, and 5012 (6,000X average coverage), and with the MiSeq system for the other seven strains (775X average coverage; Illumina, San Diego, CA, United States). Paired-end reads were also generated with Illumina GAIIx technology (1,700X average coverage) for all strains. Contigs were obtained using two *de novo* assembly tools, ABySS ([@B48]) (version 1.3.5) and CLC assembly cell (version 4.2.0)^[1](#footnote1){ref-type="fn"}^.

Strains 4788, 4235, and 35 were also sequenced with Oxford Nanopore technology using a GridIon apparatus. To generate the assemblies, a hybrid approach consisting of the assembly of long reads only and polishing of the resulting contigs with short reads was implemented. Long reads with Phred score \<Q9 and minimum length \<1,000 bp were removed with Filtlong v0.1.1^[2](#footnote2){ref-type="fn"}^. The theoretical depth of remaining reads for each seed was greater than 250X. Assembly was performed with Canu1.7 ([@B32]) using the default parameters and an expected genome size of 800 kb. Before polishing draft assemblies with Pilon 1.22 ([@B55]), Illumina reads were trimmed using Trimmomatic V0.36 ([@B6]). Sequences were annotated with Prokka v1.12 ([@B47]), using the previously published annotation of the *M. hominis* PG21 strain genome as a reference ([@B43]).

Gap Closures, Genome Analysis, and Comparisons
----------------------------------------------

Detection of contigs harboring ICE-related CDSs was performed by comparison with the previously reported genome sequences of *M. fermentans* PG18 (GenBank accession number: [AP009608](AP009608)), *M. agalactiae* 5632 (FP671138), *M. bovis* PG45 (CP002188), *M. bovis* Hubei (CP002513), and *M. mycoides* subsp. *capri* GM12 (CP001668) using MolliGen ([@B3]). The characterization of ICEHo 4788, carried by a single contig, allowed detection of contigs carrying fragments of ICEHo in the other fully sequenced strains. Gap closure between contigs carrying ICE sequences was performed by PCR and Sanger sequencing. ICE maps were drawn using Clone Manager 9 Basic Edition (Scientific & Educational Software, Denver, CO, United States).

The ICE-related CDSs were analyzed using BLAST^[3](#footnote3){ref-type="fn"}^, InterPro^[4](#footnote4){ref-type="fn"}^, MolliGen^[5](#footnote5){ref-type="fn"}^, Artemis Comparison Tool^[6](#footnote6){ref-type="fn"}^, EMBOSS Needle^[7](#footnote7){ref-type="fn"}^, TMHMM Server v.2.0^[8](#footnote8){ref-type="fn"}^, MEME analysis^[9](#footnote9){ref-type="fn"}^, RADAR^[10](#footnote10){ref-type="fn"}^, SPINE-D^[11](#footnote11){ref-type="fn"}^, PHYRE2^[12](#footnote12){ref-type="fn"}^, IsUnstruct v2.02^[13](#footnote13){ref-type="fn"}^, and PONDR^®^.^[14](#footnote14){ref-type="fn"}^

Southern Blotting Analyses
--------------------------

Southern blotting analyses were performed as described previously ([@B36]). Briefly, 1 μg of genomic DNA was separately digested with *Hin*dIII and *Eco*RV. Membranes were hybridized with digoxigenin-labeled (Roche, Mannheim, Germany) CDS1-specific or CDS22-specific probes generated by PCR ([Table 2](#T2){ref-type="table"}).

###### 

Primers used to detect the four ICE backbone CDSs (CDS1, CDS5, CDS17, CDS22) and the specific *M. hominis* ICE module.

  **Forward primers**   **Sequences of forward primers (5′-3′)**   **Reverse primers**   **Sequences of reverse primers (5′-3′)**   **Size of PCR product (bp)**
  --------------------- ------------------------------------------ --------------------- ------------------------------------------ ------------------------------
  CDS1-F cons           TTGAAATAAARGTTTTAGATGRTGAG                 CDS1-R cons           CAAACATTTGCAAATATYTAACTCCA                 290
  CDS5-F cons           TGAGATTTAGCGGTTGATGGYG                     CDS5-R cons           TACTTGRGCTGTTCCTTCYC                       771
  CDS17-F cons          TRAAGCCAAAMAAGCAAAGC                       CDS17-R cons          MGCCATTGTYGCTTGTTCATC                      581
  CDS22-F cons          TTCAGCTAGAAAATGAYGATGC                     CDS22-R cons          RCTRGTTTTAGTGGYTAAGA                       146
  MhoF cons             TCATCCCATACCCCCTCK                         MhoR-cons             TTAAAACGACCGCCTTGGTTG                      4000 to 5100

Detection of ICE-Related CDS and ICE Extrachromosomal Forms
-----------------------------------------------------------

Detection of the four conserved ICE genes (CDS1, CDS5, CDS17, and CDS22) was performed by PCR ([Table 2](#T2){ref-type="table"}). The primers for detection of the specific *M. hominis* ICE module were designed to correspond to the flanking CDSs, i.e., CDS11 for the forward primer and CDS14 for the reverse primer. The extrachromosomal ICEHo circular forms (cICEHos) were detected using outward facing primers ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}).

PCR for detection of the four conserved CDSs was carried out in a volume of 50 μL using GoTaq G2 hot start polymerase (Promega, Madison, WI, United States). Thermal cycling reactions consisted of an initial denaturation step of 15 min at 95°C followed by 30 cycles of denaturation for 1 min at 95°C, annealing for 1 min at 56°C, and extension for 2 min at 72°C, with a final extension for 5 min at 72°C.

PCR for detection of the specific *M. hominis* ICE modules was carried out in a volume of 50 μL using the Expand Long Template PCR system (Roche). Thermal cycling reactions consisted of an initial denaturation step for 2 min at 95°C followed by 15 cycles of denaturation for 10 s at 95°C, annealing for 30 s at 57°C, and extension for 2 min at 68°C, and 20 cycles of denaturation for 15 s at 95°C, annealing for 30 s at 57°C, and extension for 2 min + 20 s for each successive cycle at 68°C, with a final extension for 7 min at 68°C.

All PCR products were sent to Eurofins Genomics (Ebersberg, Germany) for sequencing. Sequencing data were analyzed using BioEdit^§^ 7.2.5 software (Isis Pharmaceuticals, Carlsbad, CA, United States).

Statistical Analysis
--------------------

The chi-squared test was used to compare the prevalence of ICEHos between isolates carrying the *tet*(M) gene and those without the *tet*(M). *P* \< 0.05 was considered significant.

Data Availability
-----------------

Illumina reads have been deposited in SRA under BioProject [PRJNA493181](PRJNA493181). Strain 4788, 4235 and 35 genome assemblies have been submitted to GenBank under the accession numbers [CP035542](CP035542), [CP038014](CP038014), and [CP035543](CP035543), respectively.

Results
=======

Detection of MICEs in *M. hominis*
----------------------------------

We first searched for the minimal ICE backbone composed of CDS1, CDS5, CDS17, and CDS22 using the Molligen database in the 12 fully sequenced *M. hominis* genomes. Three isolates, i.e., 331, 3299, and 5096, had none of the four CDSs. Two isolates, i.e., 2674 and 5060, had three CDSs (CDS1, CDS5, and CDS22), but they occurred at different loci suggesting that they were vestigial ICE remnants. The minimal ICE backbone was detected in the remaining seven isolates, suggesting the presence of complete ICEs. A full ICE, designated as ICEHo 4788, was identified in isolate 4788 and was carried by a single contig. Its organization and composition were defined and ICEHo 4788 was then used as a reference to analyze and assemble other isolates, in which ICE elements were distributed over several contigs.

*M. hominis* 4788 ICE
---------------------

ICEHo 4788 is a large genetic element of 29,180 bp, accounting for 4.1% of the *M. hominis* 4788 genome (712,285 bp). Its GC content was 27.31%, which was not significantly different from the GC content of 26.98% in the *M. hominis* 4788 genome (*P* = 0.622, χ^2^ test). Comparative analysis of ICEHo 4788 CDS synteny and amino acid (aa) identity and similarity with ICEF-II from the *M. fermentans* PG18 strain ([@B12]) and ICEA-III from the *M. agalactiae* 5632 strain ([@B36]) was performed ([Figure 1A](#F1){ref-type="fig"}, [Table 3](#T3){ref-type="table"}, and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). ICEHo 4788 contained 25 CDSs, including 13 distinct CDSs homologous to ICEF-II CDSs, which were further designated using the same nomenclature ([@B12]). The synteny was overall conserved between ICEHo 4788 and ICEF-II but CDS12 was located at different positions---downstream of CDS18 in ICEHo 4788 and downstream of CDS11 in ICEF-II ([Figure 1A](#F1){ref-type="fig"}). When compared to ICEA-III ([@B36]), only 10 distinct homologous CDSs were found in ICEHo 4788 ([Figure 1](#F1){ref-type="fig"}, [Table 3](#T3){ref-type="table"}, and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Overall, the percentages of similarity and identity between CDSs of ICEHo 4788 and ICEA-III were lower than those between ICEHo 4788 and ICEF-II ([Table 3](#T3){ref-type="table"} and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). Using TMHMM and InterPro softwares, six CDSs (CDS5, CDS14, CDS15, CDS16, CDS17, and CDS19) were shown in ICEHo 4788 to harbor transmembrane domains in comparison to eight CDSs previously described in ICEF-II (CDS4, CDS5, CDS7, CDS14, CDS15, CDS16, CDS17, CDS19) ([@B12]) and seven in ICEA-III (CDS5, CDS7, CDS14, CDS15, CDS16, CDS17, CDS19) ([@B36]). Marked differences were observed with *M. fermentans*, as six ICEF-II CDS homologs were lacking in ICEHo 4788 (CDS2, CDS4, CDS6, CDS7, CDS8, CDS13) and eight ICEHo 4788 CDSs had no homology with ICEF-II CDSs, nor with CDSs described previously in MICEs. These specific CDSs were designated as Mho plus a letter (MhoA to MhoK). Their best NCBI Blast hits retrieved mainly hypothetical proteins and methyltransferases from bacteria belonging to the same urogenital environment, such as *Ureaplasma parvum*, *Candidatus* Mycoplasma girerdii, and *Finegoldia magna* ([Table 4](#T4){ref-type="table"}).

![Genetic organization of integrative and conjugative elements (ICEs) from *M. hominis*, *M. agalactiae*, and *M. fermentans*. **(A)** Comparison of ICEs present in *M. hominis* 4788 (ICEHo 4788), *M. agalactiae* 5632 (ICEA-III), and *M. fermentans* PG18 (ICEF-II). **(B)** Genetic organization of the specific *M. hominis* ICE module in the ICEHos of the seven sequenced *M. hominis* strains harboring complete ICEHos. ICEs are designated according to their originally proposed names. *M. hominis* ICEs are designated with same number as the *M. hominis* strain from which they are originated from (e.g., ICEHo 4788 is from *M*. *hominis* 4788 strain). Arrows represent coding sequences (CDSs), hatched arrows represent pseudogenes. Homologous CDSs are identified by the same color and same number or letter underneath, using previously described nomenclature. ICEHo 4788 CDSs that had no homology with CDSs reported previously in mycoplasma ICEs (MICEs) were designated as Mho plus a letter (MhoA to MhoK).](fmicb-10-02385-g001){#F1}

###### 

Comparison of CDSs from *M. hominis* ICEHo 4788 with CDSs from *M. fermentans* PG18 ICEF-II and *M. agalactiae* 5632 ICEA-III.

  ***M. fermentans* PG18 ICEF-II**   ***M. agalactiae* 5632 ICEA-III**                                                                                                                         
  ---------------------------------- ----------------------------------- ------ ------ ----------------- ----------------- ----------------- ------ ------ ----------------- ----------------- -----------------
  CDS1                               263                                 263    290    32.8 (95/290)     46.9 (136/290)    18.6 (54/290)     264    300    25.3 (76/300)     44.3 (133/300)    24.3 (73/300)
  CDS3                               413                                 400    422    37.2 (157/422)    58.3 (246/422)    7.3 (31/422)      None   None   None              None              None
  CDS5                               766                                 740    811    35.8 (290/811)    54.3 (440/811)    14.3 (116/811)    670    813    32.7 (266/813)    49.8 (405/813)    23.4 (190/813)
  MhoI                               335                                 None   None   None              None              None              None   None   None              None              None
  CDS11                              252                                 238    260    30.4 (79/260)     50.4 (131/260)    11.5 (30/260)     221    302    14.9 (45/302)     27.8 (84/302)     43.4 (131/302)
  MhoH                               266                                 None   None   None              None              None              None   None   None              None              None
  MhoG                               102                                 None   None   None              None              None              None   None   None              None              None
  MhoF                               328                                 None   None   None              None              None              None   None   None              None              None
  MhoE                               63                                  None   None   None              None              None              None   None   None              None              None
  MhoC                               169                                 None   None   None              None              None              None   None   None              None              None
  CDS14                              562                                 552    611    24.4 (147/611)    43.4 (261/611)    21.1 (129/611)    525    622     22.8 (142/622)   40.8 (254/622)    25.2 (157/622)
  CDS15                              120                                 95     126    25.4 (32/126)     39.7 (50/126)     29.4 (37/126)     121    126    29.4 (37/126)     50.8 (64/126)     8.7 (11/126)
  CDS16                              400                                 396    416    27.4 (114/416)    47.1 (196/416)     8.7 (36/416)     357    434    22.4 (97/434)     38.9 (169/434)    25.6 (111/434)
  CDS17                              927                                 937    955    39.8 (380/955)    59.1 (564/955)     4.8 (46/955)     928    950    40.2 (382/950)    60.0 (570/950)    4.7 (45/950)
  CDS18                              260                                 227    281    24.9 (70/281)     45.6 (128/281)    26.7 (75/281)     None   None   None              None              None
  CDS12                              130                                 183    195    26.2 (51/195)     39.0 (76/195)     39.5 (77/195)     134    142    24.6 (35/142)     50.0 (71/142)     14.1 (20/142)
  CDS19                              1434                                1424   1566   28.0 (439/1566)   45.0 (704/1566)   17.5 (274/1566)   1517   1720   24.8 (426/1720)   39.1 (673/1720)   28.4 (489/1720)
  MhoK                               363                                 None   None   None              None              None              None   None   None              None              None
  MhoA                               232                                 None   None   None              None              None              None   None   None              None              None
  CDS21                              286                                 313    325    56.6 (184/325)    65.2 (212/325)    15.7 (51/325)     None   None   None              None              None
  CDS22                              396                                 390    427    23.2 (99/427)     36.3 (155/427)    34 (145/427)      378    412    23.8 (98/412)     36.4 (150/412)    30.8 (127/412)
  MhoJ*^*a*^*                        464                                 None   None   None              None              None              None   None   None              None              None

Percentages of amino acid identity and similarity were determined using EMBOSS Needle. ICEF-II: second ICE of

M. fermentans

PG18 (

Calcutt et al., 2002

). ICEA 5632-III: third copy of ICE in

M. agalactiae

5632 (

Marenda et al., 2006

).

a

MhoJ is not harbored by

M. hominis

4788, but is harbored by the six other sequenced

M. hominis

strains harboring ICEs.

###### 

Major features of specific *M. hominis* ICE CDSs.

  **Specific *M. hominis* ICE CDSs**   **ICEHo CDS size (aa)**   **NCBI best Blast hit^a^**             **Organism**                ***E*-value^a^**   **% coverage^a^**   **% Identity^a^**   **Best Blast hit size (aa)**   **Length of align ment^b^ (aa)**   **% identity vs. best Blast hit^b^**   **% similarity vs. best Blast hit^b^**   **% gaps vs. best Blast hit^b^**
  ------------------------------------ ------------------------- -------------------------------------- --------------------------- ------------------ ------------------- ------------------- ------------------------------ ---------------------------------- -------------------------------------- ---------------------------------------- ----------------------------------
  MhoI                                 335                       DNA cytosine methyl transferase        *Ureaplasma parvum*         1e-129             59                  92.5                200                            335                                55.2 (185/335)                         56.7 (190/335)                           40.3 (135/335)
  MhoH                                 266                       Hypothetical protein                   *Finegoldia magna*          6e-44              81                  46                  300                            336                                33.0 (111/336)                         45.8 (154/336)                           31.5 (106/336)
  MhoG                                 102                       Hypothetical protein                   *Ca.* Mycoplasma girerdii   4e-8               35                  78                  179                            190                                23.2 (44/190)                          32.1 (61/190)                            52.1 (99/190)
  MhoF                                 328                       Hypothetical protein                   *Finegoldia magna*          3e-53              90                  41                  300                            366                                34.4 (126/366)                         48.9 (179/366)                           28.4 (104/366)
  MhoE                                 63                        Hypothetical protein                   *Mycoplasma fermentans*     7e-13              95                  52                  60                             63                                 49.2 (31/63)                           71.4 (45/63)                             4.8 (3/63)
  MhoC                                 169                       Phage protein                          *Mycoplasma hyorhinis*      3e-53              97                  50                  223                            223                                37.2 (83/223)                          52.9 (118/223)                           24.2 (54/223)
  MhoK                                 363                       Site-specific DNA methyl transferase   *Ureaplasma parvum*         0                  100                 97                  363                            363                                96.7 (351/363)                         98.1 (356/363)                           0 (0/363)
  MhoA                                 232                       Hypothetical protein                   *Ureaplasma parvum*         5e-158             99                  96                  264                            264                                83.7 (221/264)                         86.7 (229/264)                           12.1 (32/264)
  MhoJ^*c*^                            464                       Hypothetical protein                   *Ca.* Mycoplasma girerdii   4e-43              50                  66                  179                            472                                25.6 (121/472)                         30.5 (144/472)                           63.8 (301/472)

a

Determined using BLAST.

b

Percentages of amino-acid identity and similarity with the NCBI best BLAST hits were determined using EMBOSS Needle.

c

MhoJ is not harbored by

M. hominis

4788 but is harbored by the six other sequenced

M. hominis

strains harboring ICEs.

Common and Specific Features of *M. hominis* ICEs
-------------------------------------------------

In addition to ICEHo 4788, complete ICEs were detected and characterized in six strains (ICEHo 35-I, ICEHo 132, ICEHo 3631, ICEHo 4016, ICEHo 4235-I, and ICEHo 5012) ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). Overall, ICEHos showed a similar structure except for the occurrence of MhoA as a pseudogene, which was only present in ICEHo 4788 ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). All ICEHos contained a 4.0--5.1-kb module composed of five to six juxtaposed CDSs, i.e., MhoJ, MhoH, MhoG, MhoF, MhoE, and MhoC, the synteny of which varied slightly among the strains, as shown in [Figure 1B](#F1){ref-type="fig"}. All of the genes forming this module were specific to *M. hominis* ICEs (see below for detailed description) as they had no homologs in other MICEs.

*M. hominis* ICEHo May Occur as Multiple Copies
-----------------------------------------------

Southern blot hybridization data using labeled CDS1 and CDS22 probes and *Eco*RV-digested chromosomal DNA suggested the presence of a single chromosomal ICEHo in *M. hominis* strains 3631, 132, 4016, 4788, and 5012, and the presence of at least two ICEHo copies in strains 4235 and 35 ([Supplementary Figure S2](#FS2){ref-type="supplementary-material"}). Southern blot hybridization performed with *Hin*dIII-digested chromosomal DNA yielded the same results (data not shown). In strains 4235 and 35, Illumina sequencing retrieved a single copy of ICEHo due to the limits of the assembly process based on short reads only. To overcome this issue, the genomes of *M. hominis* strains 4788, 4235, and 35 were sequenced using Oxford Nanopore technology that can generate long reads. The combined assembly of Oxford Nanopore and Illumina reads confirmed the presence of a single ICEHo in strain 4788 and revealed the occurrence of two ICEHo 4235 copies in *M. hominis* 4235, namely ICEHo 4235-I of 30.5 kb at position 397,452--428,015 and ICEHo 4235-II at position 778,637--809 029 (GenBank accession number [CP038014](CP038014)). The two copies showed 99.0% sequence identity and were in opposite orientation within the genome of *M. hominis* 4235. In *M. hominis* strain 35, the presence of two ICEHo copies, namely ICEHo 35-I of 30.3 kb (position 449,355--479,744) and ICEHo 35-II of 29.1 kb (position 312,315 to 341,498) (GenBank accession number [CP035543](CP035543)) was also confirmed. These two copies were in the same orientation within the genome and showed 90.0% sequence identity.

Extrachromosomal Circular Forms and Sites of Integration of ICEHos
------------------------------------------------------------------

One piece of evidence for ICE functionality is the detection of a circular form due to chromosomal excision. To detect these cICEHos in *M. hominis*, outward facing primers located at both ends of the chromosomal ICEs were designed for all strains ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). PCR products were detected for five strains, i.e., *M. hominis* 4788, 3631, 35, 132, and 4235, and the cICEHo junctions previously designated as cirboxes ([@B51]) were sequenced ([Figure 2A](#F2){ref-type="fig"}). As shown in [Figure 2B](#F2){ref-type="fig"}, these sequences encompassed the downstream region of CDS22, a non-coding region, an imperfect inverted repeat (IR), a 6-bp coupling sequence corresponding to a juxtaposition of the two 8-bp direct repeats that flank the ICEHo, an imperfect IR, and a non-coding region located upstream of CDS1 ([Figure 2A](#F2){ref-type="fig"}). Cirbox sequences were highly conserved with 92% identity between cirboxes of ICEHo 4788, ICEHo 3631, ICEHo 35-I, ICEHo 132, and ICEHo 4235-I. The length of the non-coding regions between CDS22 and the IR, and between the IR and CDS1 were similar, ranging between 368 and 407 nt and between 171 and 204 nt, respectively. The 6-bp coupling sequences differed between strains ([Figure 2B](#F2){ref-type="fig"}). No cICEHo was detected for ICEHo 4016 or ICEHo 5012, but we noted that these two ICEs had truncated ends ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). Indeed, ICEHo 4016 CDS1 comprised only 171 aa compared to 263 aa for the other ICEHo CDS1 (35% loss of length). ICEHo 5012 CDS22 was comprised of 142 aa and was thus shorter than the other ICEHo CDS22 (396 aa; 36% loss of length). Furthermore, IRs and direct repeats were not found in ICEHo 5012 or ICEHo 4016.

![Chromosomal and extrachromosomal circular forms of ICEHo. **(A)** Schematic representation of the chromosomal loci containing ICEHos in the five sequenced *M. hominis* strains harboring ICEHos able to circularize. The chromosomal ICEs possess two imperfect inverted repeats (IRs, represented by a gray triangle) at each end that are flanked by two 8-bp direct repeats (DRs, represented by a black rectangle). **(B)** Extrachromosomal ICEHo circular forms with details of the 6-bp coupling sequences. Excision and circularization from the *M. hominis* donor chromosome resulted in a free circular form, in which the junction contains a 6-bp coupling region. This coupling region corresponds to a juxtaposition of the DRs flanking the ICEHo.](fmicb-10-02385-g002){#F2}

The chromosomal locations of ICEHos are shown in [Supplementary Figure S3](#FS3){ref-type="supplementary-material"}. The results indicated that ICEHos could insert in either coding or non-coding regions without any target specificity.

Analysis of the Specific *M. hominis* ICE Module
------------------------------------------------

Further analysis of the specific *M. hominis* ICE module highlighted that in MhoH, MhoG, MhoF, and MhoJ, an absolutely conserved sequence of 23 aa (SSLSDFDKTPTDLKDSKVINEYN) was present within the last 40 residues of the sequences ([Figure 1](#F1){ref-type="fig"}). This conserved sequence was also detected in CDS11 and CDS21, but a Prosite search failed to retrieve functional motifs. The conserved sequence contained a large number of charged amino acids, with five D/E and three K residues, and was also found in a hypothetical protein from *Candidatus* Mycoplasma girerdii (MGM1_3750). The C-terminal part of the proteins containing this conserved motif was predicted to be disordered using SPINE-D, Phyre2, and IsUnstruct v2.02, and was enriched in putative phosphorylation sites (prediction using DEPP^®^ server) ([Supplementary Figure S4](#FS4){ref-type="supplementary-material"}).

In the search for additional insights regarding the putative function of ICEHo 4788 proteins, *in silico* analysis using Phyre2 (secondary and tertiary structure elements) and RADAR (direct repeat) algorithms was performed for detailed analysis of the primary protein sequences. A modeled partial structure was obtained using Phyre2 for the 10 proteins listed in [Table 5](#T5){ref-type="table"}. All proteins for which a structure was obtained, except MhoK, were predicted to share structural similarities to DNA interacting/modifying proteins. Phyre2 analysis of secondary structures in MhoF and MhoH revealed a high content of α-helices, organized in a tight stretch of supersecondary elements consisting of α-helices linked by short loops. Phyre2 3-D structure prediction indicated that both proteins shared common structural features with transcription activator-like (TAL) effectors ([Table 5](#T5){ref-type="table"}). The highest scoring templates leading to modeling of MhoF and MhoH structures were structures of the TAL effector AvrBs3/PthA for MhoF and the second copy of ICEHo 4788 MhoH (98 and 95% coverage, respectively), and BurrH DNA binding protein for the first copy of MhoH (97% coverage). The modeled structure obtained for MhoF is shown in [Figure 3A](#F3){ref-type="fig"}. Similar to BurrH and in contrast to typical TAL effectors, such as AvrBs3, MhoF and MhoH do not possess any recognizable nuclear localization signal (NLS) sequence, N-terminal type III secretion signal or activation domain at the C-terminus.

###### 

Phyre2 models for ICEHo 4788 proteins.

  **ICEHo 4788**   **Phyre 2 top hit template**                                                                                                                           
  ---------------- ------------------------------ --------------------------------------------------------------------- -------------------------------------- ---------- ------
  CDS3             c4lvjA                         MobM relaxase domain                                                  *Streptococcus agalactiae*             31 (126)   97.6
  CDS5             d1eçRa                         RecA protein like (ATPase domain)                                     *Escherichia coli*                     51 (392)   100
  MhoI             d2c7pa1                        C5 cytosine DNA methyltransferase DCM                                 *Haemophilus haemolyticus*             95 (319)   100
  MhoH-1           c4cj9A                         DNA binding protein BurrH                                             *Burkholderia rhizoxinica*             97 (262)   100
  MhoH-2           c3UGmA                         TAL effector PthXo1                                                   *Xanthomonas oryzae* pv. *oryzae*      95 (253)   100
  MhoF             c3UGmA                         TAL effector PthXo1                                                   *Xanthomonas oryzae* pv. *oryzae*      98 (322)   100
  MhoC             c1aqjB                         N6 adenine DNA methyltransferase *Taq*I                               *Thermus aquaticus*                    72 (121)   99.6
  CDS17            c4ag5a                         Type IV secretory pathway component VirB4                             *Thermoanaeobacter pseudethanolicus*   40 (373)   100
  CDS12            c1qvcA                         Single stranded DNA binding Protein 2                                 *Escherichia coli*                     95 (123)   100
  MhoK             d1G60A                         *S*-adenosyl-[L]{.smallcaps}-methionine-dependent methyltransferase   *Moraxella bovis*                      64 (233)   100

Only models of proteins for which coverage was higher than 120 amino acids, associated with a confidence higher than 95%, are listed.

![**(A)** Predicted structure for MhoF (residues 2--320) modeled using Phyre2. Variable residues (putative repeat variable di-residue \[RVD\]) at positions 12 and 13 of the double helix are shown using balls and sticks representation. **(B)** Repeated sequences in MhoF and MhoH sequences. The repeated sequences identified using the RADAR algorithm were further refined using Phyre2 alignments. Repeats were aligned using Clustal Omega. Amino acids (aa) with similar physicochemical properties are shown in the same color: red, small and hydrophobic aa; blue, acidic aa; magenta, basic aa; green, hydroxyl, sulfhydryl, and amine aa. The two residues of the double helix that are not repeated are indicated in black. Most variable di-residues within MhoF repeats, and corresponding di-residues in MhoH, are shown in boxes. ^∗^Conserved residues among repeats for each protein without taking into account the truncated repeats. The multilevel consensus sequence was identified using MEME software.](fmicb-10-02385-g003){#F3}

Combination of Phyre2 alignments and RADAR results allowed identification of eight 32-residue long repeats in MhoF, and six repeats of the same length in both MhoH sequences in ICEHo 4788 ([Figure 3B](#F3){ref-type="fig"}). In all proteins, the full-length repeats were flanked by two supplementary truncated repeats. In addition, the C-terminal ends of all three proteins were predicted to form a double helix containing two cryptic repeats, which included the 23-aa conserved motif. Alignment of the whole set of 32-residue long repeats found in MhoF and MhoH sequences using Clustal Omega revealed the presence of eight strictly conserved aa ([Figure 3B](#F3){ref-type="fig"}). Following the Phyre2 model ([Figure 3A](#F3){ref-type="fig"}), repeats were associated to form a structure based on successive two-helix bundles. Whereas in typical TAL effectors repeated sequences are almost identical, except at positions 12 and 13 corresponding to the repeat variable di-residue (RVD) motif involved in nucleotide recognition, a high degree of polymorphism of Mho TAL-like repeats was observed. Nonetheless, at positions 12 and 13 of the repeats in MhoF, variable residues (KG, FN, NG, and HG) exposed in interhelical loops were identified as the putative RVD. The other highly variable positions were positions 20 and 21 of each repeat of MhoF, but the corresponding residues were part of the helical structures predicted using Phyre2. The truncated repeats (1st and 10th repeats) in MhoF did not contain a putative RVD. Examination of MhoH sequences suggested that QG may also correspond to an RVD ([Figure 3B](#F3){ref-type="fig"}).

Prevalence of ICEHo in a Collection of 120 *M. hominis* Clinical Isolates
-------------------------------------------------------------------------

To define the prevalence of ICEHo in the *M. hominis* strains, the four CDSs that are part of the minimal ICE backbone (CDS1, CDS5, CDS17, and CDS22) and the specific *M. hominis* ICE module were searched by PCR in a panel of 120 *M. hominis* clinical isolates ([Table 6](#T6){ref-type="table"}). A complete ICEHo was considered present when the four CDSs and the specific *M. hominis* ICE module were detected. The data showed that 45% of the isolates possessed the four CDSs and the specific *M. hominis* ICE module, suggesting the presence of complete ICEHos. In 35% of isolates, none of the four CDSs or the specific *M. hominis* ICE module were detected, suggesting the absence of ICEHo. The remaining 20% of clinical isolates harbored one, two or three CDSs, suggesting the presence of potential ICEHo remnants ([Table 6](#T6){ref-type="table"}). The specific *M. hominis* ICE module was present in 54.5% (6/11) of strains harboring three backbone CDSs. Among the 27 *M. hominis* isolates carrying the *tet*(M) gene, the prevalence of the four CDSs and the specific *M. hominis* module was 48.1% (13/27), whereas among the 93 *M. hominis* isolates not carrying the *tet*(M) gene, the prevalence of the four CDSs and the specific *M. hominis* module was 44.1% (41/93). There was no significant difference in the prevalence of ICEHos between isolates carrying the *tet*(M) gene and those without the *tet*(M) gene (*P* = 0.85, χ^2^ test).

###### 

Distribution of the four ICE backbone CDSs and the specific *M. hominis* ICE module in 120 clinical isolates of *M. hominis.*

  ------------------------------
  ![](fmicb-10-02385-i001.jpg)
  ------------------------------

Discussion
==========

Since their discovery, MICEs have been found distributed among several mycoplasma species ([@B12]; [@B36]; [@B52]; [@B56]; [@B51]) and there is accumulating evidence that they play a pivotal role in HGTs of large DNA fragments ([@B18]; [@B19]; [@B14]). This report provides the first description of ICE in *M. hominis* and highlights their specific and new features.

The previously reported MICE backbone, comprised of CDS1, CDS5, CDS17, and CDS22, was found ([@B51]) in *M. hominis* ICEs. These four CDSs were demonstrated to be part of the minimal ICE machinery using a transposon-based strategy in *M. agalactiae* ([@B2]). The gene repertoire and organization of CDSs in ICEHo were similar to those reported in *M. agalactiae* ([@B36]) and *M. fermentans* ([@B12]), two other species belonging to the Hominis phylogenetic group. Thus, ICEHos also belong to the previously designated "hominis" MICE type ([@B51]). Notably, five CDSs (CDS5, CDS15, CDS16, CDS17, and CDS19) harboring transmembrane domains and previously described as candidates for conjugative channel formation ([@B14]), were identified in ICEHos. CDS14, a surface-exposed lipoprotein essential for mycoplasma conjugation and predicted to initiate cell-to-cell contact in the first step of conjugation ([@B2]; [@B14]), was also identified in ICEHos as well as CDS22, encoding the DDE recombinase essential for ICE excision and integration ([@B2]; [@B14]). These observations raised questions regarding the functionality of ICEHos. As the first step in conjugative ICE transfer is excision from the chromosome, we searched for circular extrachromosomal forms and these were found in five of the seven strains harboring ICEHos. Interestingly, the two ICEHos for which no circular forms were found had truncated ends, i.e., the 3′ end of CDS1 in ICEHo 4016 and the 5′ end of CDS22 in ICEHo 5012 ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). The absence of IRs at both extremities of ICEHo 5012 and ICEHo 4016 was also noted, suggesting that both complete 3′ and 5′ ends of the ICEHo are required for excision from the chromosome. In contrast, the 3′ end of ICEA CDS1 was shown to be non-essential in *M. agalactiae*, as miniICEs composed of IRs and the first 470 nt of CDS1 were able to circularize ([@B18]). Mating experiments are needed to confirm the capacity of ICEHos to transfer. However, the transformation of *M. hominis* is problematic (Bébéar et al., personal data) and to date no *M. hominis* transformants harboring an ICEHo marked by an antibiotic resistance gene marker have been obtained, thus limiting the possibility of performing such experiments.

As previously reported in MICE ([@B14]), the present study showed that *M. hominis* strains can carry a single or two similar ICEHo copies. The insertion sites of ICEHo in the chromosome were variable and could occur within CDSs, suggesting that the DDE recombinase encoded by CDS22 has no specific target site and that random insertion may sometimes have deleterious effects. The prevalence of ICEHo in *M. hominis* strains was high, i.e., 45% in a collection of 120 *M. hominis* clinical isolates. This prevalence may have been slightly underestimated because six additional strains (5%) harbored the specific *M. hominis* ICE module and three of the four backbone CDSs. We cannot exclude the possibility that the fourth CDS would not have been detected by PCR due to slight modifications of the gene sequence. In addition, CDS1, CDS5, CDS17, CDS22 and the specific *M. hominis* ICE module are also present in two previously published genome datasets for two other clinical isolates, *M. hominis* PL5 (GenBank JRXA01000000) and *M. hominis* TO0613 (GenBank CP033021). Overall, this 45% prevalence was equivalent to that of 47% (78/166) found in a collection of four ruminant mycoplasma species ([@B51]). It should also be noted that CDS22 from ICEHo 4788 has a match in the genome of *U. parvum* serovar 14 (ATCC 33697), another human mycoplasma sharing the same genital niche. Thus, ICEs appear to be widespread both within animal and human mycoplasmas. The maintenance of such genetic mobile elements in genomes, as small as those of mycoplasmas, supports the hypothesis that MICEs may confer a positive advantage for the physiology or pathogenicity of the bacterium. Nevertheless, the prevalence of ICEs was not higher in isolates carrying the *tet*(M) gene responsible for tetracycline resistance. This suggests that *tet*(M)-mediated tetracycline resistance is not attributable to ICEHos in *M.* hominis. Indeed, in previously sequenced strains harboring the *tet*(M) gene, the resistance gene was carried by a transposon that integrated into the *rumA* gene in a site-specific manner ([@B1]; [@B9]; [@B13]), which is not a gene carried by *M. hominis* ICEs. However, when focusing on isolates harboring no ICE-specific CDSs in their genome, it was noted that 43% (40/93) were *tet*(M)-negative strains, whereas only 7.4% (2/27) were *tet*(M)-positive strains (*P* \< 0.01). This finding suggests a possible association between the absence of ICE and the absence of the *tet*(M) gene in the genome. Therefore, we speculated that *M. hominis* strains that do not carry ICEs may be less susceptible than others to the entry of foreign DNA, such as the *tet*(M) gene, by HGT. The reason for this phenomenon is unknown, but it will be of interest to screen for differences in the nature and number of restriction-modification systems between such strains.

The major difference with previously reported MICEs was the presence of a specific *M. hominis* ICE module, not found in other MICEs, composed of five to six juxtaposed CDSs that had no orthologs with any MICE CDSs, and no predicted transmembrane domains. Interestingly, Phyre2 3-D structure prediction indicated that two proteins, MhoF and MhoH, share common structural features with TAL effectors, found in *Xanthomonas* spp. and in *Ralstonia solanacearum* ([@B29]; [@B15]), and with BurrH from *Burkholderia rhizoxinica* ([@B31]; [@B50]). TAL effectors are heterogeneous transcription factors involved in polynucleotide recognition and signal transduction, and are delivered into plant cells by pathogenic bacteria *via* a type III secretion system ([@B20]; [@B42]). Many TAL effectors are important virulence factors ([@B46]; [@B4]; [@B33]). The results of *in silico* analysis indicated that *mhoF* and *mhoH* are phylogenetically related and belong to the same multigene family. They most likely appeared by duplication and their sequences have diverged gradually during evolution.

Our study raised the question of whether MhoF and MhoH retained DNA-binding capability similar to BurrH, which also lacks typical TAL effector features other than repeats ([@B31]; [@B50]). Considering the predicted structural elements, DNA-binding properties of MhoH and more especially of the larger MhoF cannot be excluded. Indeed, MhoF has a double-helix structure similar to the minimal functional TAL effectors ([@B5]) ([Figure 3A](#F3){ref-type="fig"}). The identified putative RVDs in MhoF and MhoH sequences include the di-residues KG, FN, NG, HG, and QG. Extensive studies using natural or artificial RVDs showed that NG, HG, QG, and KG specifically or preferentially bind thymine, while FN preferentially binds guanine ([@B5]; [@B58]; [@B39]). However, the genes encoding the bacterial apparatus, which would be required if these proteins were secreted, have not yet been identified in *M. hominis*. Nevertheless, *M. hominis* ICEs encode a putative type IV secretion system (T4SS). Although to date TAL effectors have only been associated with type III secretion systems, it remains possible that *M. hominis* ICE repeat-containing proteins could be transferred through this T4SS, either as free proteins or as proteins bound to DNA. Indeed, T4SS were shown to translocate proteins (effectors), DNA or DNA--protein complexes ([@B27]). Further studies are therefore needed to determine whether MhoF and MhoH retain DNA-binding capacity and can be transferred through a T4SS, or if another secretion system is involved. In addition, as some TAL RVDs are involved in the recognition of modified nucleotides ([@B17]), MhoF and MhoH may act together with other ICEHo proteins, such as MhoI and MhoK, which are predicted methyltransferases. The presence of such systems in *M. hominis* may be relevant for its survival, pathogenicity and/or virulence. Interestingly, *M. hominis* was shown to undergo endosymbiosis with *Trichomonas vaginalis*, a human urogenital pathogenic protozoa responsible for sexually transmitted infections. This symbiosis was observed in up to 94% of clinical isolates of *T. vaginalis* ([@B44]; [@B25]), and it was recently reported that *M. hominis* has an impact on the gene expression of *T. vaginalis* ([@B25]). As TAL effectors were only reported in bacteria able to live in symbiosis with other organisms, we speculate that ICEHos harboring TAL-like effectors may provide favorable properties to *M. hominis* and/or *T. vaginalis*, to enable survival in their environment.

In addition, a conserved motif of 23 aa localized within intrinsically disordered domains (IDRs) was found in several proteins of ICEHo. IDRs are involved in essential cell processes through two basic mechanisms, i.e., the entropic chain mechanism responsible for rapid fluctuations among many alternative conformations and molecular recognition via short recognition elements ([@B40]). They were previously described in *M. pneumoniae* ([@B41]) and *M. genitalium* ([@B21]). It is not surprising to find IDRs in mobile elements, such as ICEHos, because plasmid-encoded proteins were shown to contain considerably more IDRs than chromosome-encoded proteins ([@B40]). This motif was only found in a hypothetical protein of *Ca. Mycoplasma girerdii* (MGM1_3750). *Ca. M. girerdii* is an uncultivated urogenital mycoplasma recently identified in vaginal samples by a metagenomic strategy ([@B37]). As per *M. hominis*, *Ca. M. girerdii* is tightly associated with *T. vaginalis* ([@B24]). Notably, *T. vaginalis*, *Ca. M. girerdii*, and *M. hominis* are able to co-localize in the vaginal tract ([@B24]), suggesting the possibility of HGT between the two urogenital mycoplasma species.

Conclusion
==========

This study described the presence of ICEs in almost half of all *M. hominis* clinical isolates and these MGEs are unlikely to be associated with the antibiotic resistance *tet*(M) gene. All *M. hominis* ICEs include a specific *M. hominis* module harboring proteins that share common structural features with TAL effectors involved in polynucleotide recognition and signal transduction in symbiotic bacteria. This type of ICE may confer a selective advantage on the bacteria to allow survival in their environment, or transformation to pathogenic status, but further experiments are needed to check their functionality in the *M. hominis* species.
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